← Back to Clinical Trials
Recruiting NCT06001502

NCT06001502 The Effect of Virtual Reality on Postoperative Pain and Anxiety in Cardiac Surgery.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06001502
Status Recruiting
Phase
Sponsor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Condition Post Operative Pain
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2023-01-01
Primary Completion 2024-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Virtual Reality distraction therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2023-01-01 with a primary completion date of 2024-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to investigate the effect of VR on post-operative pain and anxiety management in cardiac surgery patients undergoing a coronary artery bypass grafting (CABG) procedure. Participants in the intervention group will receive a 20 minute session with the head mounted VR device on post-operative days 1,2 and 3. Participants in the control group will be treated with conventional post-operative care.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years or older with written informed consent * Patients undergoing surgical CABG Exclusion Criteria: * Major comorbidities besides coronary artery disease * Complicated surgical procedure * Hearing and/or visual impairments * Psychiatric impairments * Complaints of vomiting and nausea * History of epilepsy * Claustrophobia * Facial wounds and skin defects at site of application * Patients placed in clinical isolation * Readmission to the intensive care unit

Contact & Investigator

Central Contact

Sulayman El Mathari, MD

✉ s.elmathari@amsterdamumc.nl

📞 +31205668188

Principal Investigator

Jolanda Kluin, MD, PhD

PRINCIPAL INVESTIGATOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Frequently Asked Questions

Who can join the NCT06001502 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Post Operative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06001502 currently recruiting?

Yes, NCT06001502 is actively recruiting participants. Contact the research team at s.elmathari@amsterdamumc.nl for enrollment information.

Where is the NCT06001502 trial being conducted?

This trial is being conducted at Amsterdam, Netherlands.

Who is sponsoring the NCT06001502 clinical trial?

NCT06001502 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The principal investigator is Jolanda Kluin, MD, PhD at Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology